Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.14 USD | +1.85% | +1.90% | +10.17% |
09-16 | Ant Group to Refinance Up to $6.5 Billion Offshore Debt Facility | MT |
09-12 | China's Ant Group refinancing $6.5 billion credit line | RE |
Fiscal Period: March | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 510B | 717B | 853B | 869B | 941B | |||||
Total Revenues | 510B | 717B | 853B | 869B | 941B | |||||
Cost of Goods Sold, Total | 280B | 420B | 539B | 549B | 586B | |||||
Gross Profit | 230B | 298B | 314B | 320B | 355B | |||||
Selling General & Admin Expenses, Total | 78.87B | 119B | 152B | 146B | 157B | |||||
R&D Expenses | 43.08B | 57.24B | 55.46B | 56.74B | 52.26B | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 12.51B | 12.43B | 10.67B | 11.58B | 6.74B | |||||
Other Operating Expenses, Total | 134B | 188B | 218B | 214B | 216B | |||||
Operating Income | 95.53B | 110B | 96.5B | 106B | 139B | |||||
Interest Expense, Total | -5.18B | -4.48B | -4.91B | -5.92B | -7.95B | |||||
Interest And Investment Income | 72.96B | 72.79B | - | - | - | |||||
Net Interest Expenses | 67.78B | 68.32B | -4.91B | -5.92B | -7.95B | |||||
Income (Loss) On Equity Invest. | -5.73B | 6.98B | 14.34B | -8.06B | -7.74B | |||||
Currency Exchange Gains (Loss) | -514M | - | - | - | - | |||||
Other Non Operating Income (Expenses) | 7.95B | 7.58B | 10.52B | 5.82B | 6.16B | |||||
EBT, Excl. Unusual Items | 165B | 192B | 116B | 97.96B | 129B | |||||
Impairment of Goodwill | -576M | - | -25.14B | -2.71B | -10.52B | |||||
Gain (Loss) On Sale Of Investments | - | - | -15.7B | -11.07B | -9.96B | |||||
Asset Writedown | -3.53B | -1.69B | -1.72B | -3.06B | -14.85B | |||||
Legal Settlements | - | -18.23B | - | - | - | |||||
EBT, Incl. Unusual Items | 161B | 173B | 73.89B | 81.12B | 93.86B | |||||
Income Tax Expense | 20.56B | 29.28B | 26.82B | 15.55B | 22.53B | |||||
Earnings From Continuing Operations | 140B | 143B | 47.08B | 65.57B | 71.33B | |||||
Net Income to Company | 140B | 143B | 47.08B | 65.57B | 71.33B | |||||
Minority Interest | 9.08B | 7.29B | 15.17B | 7.21B | 8.68B | |||||
Net Income - (IS) | 149B | 151B | 62.25B | 72.78B | 80.01B | |||||
Preferred Dividend and Other Adjustments | 170M | 270M | 290M | 274M | 268M | |||||
Net Income to Common Incl Extra Items | 149B | 150B | 61.96B | 72.51B | 79.74B | |||||
Net Income to Common Excl. Extra Items | 149B | 150B | 61.96B | 72.51B | 79.74B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 56.82 | 55.62 | 22.99 | 27.65 | 31.61 | |||||
Basic EPS - Continuing Operations | 56.82 | 55.62 | 22.99 | 27.65 | 31.61 | |||||
Basic Weighted Average Shares Outstanding | 2.63B | 2.7B | 2.69B | 2.62B | 2.52B | |||||
Net EPS - Diluted | 55.92 | 54.68 | 22.74 | 27.46 | 31.24 | |||||
Diluted EPS - Continuing Operations | 55.92 | 54.68 | 22.74 | 27.46 | 31.24 | |||||
Diluted Weighted Average Shares Outstanding | 2.67B | 2.75B | 2.72B | 2.64B | 2.54B | |||||
Normalized Basic EPS | 42.72 | 47.22 | 32.64 | 26.1 | 35.45 | |||||
Normalized Diluted EPS | 42.06 | 46.44 | 32.3 | 25.93 | 35.14 | |||||
Dividend Per Share | - | - | - | 6.87 | 7.22 | |||||
Payout Ratio | - | - | - | - | 22.43 | |||||
American Depositary Receipts Ratio (ADR) | 8 | 8 | 8 | 8 | 8 | |||||
Supplemental Items | ||||||||||
EBITDA | 138B | 157B | 142B | 153B | 183B | |||||
EBITA | 117B | 131B | 117B | 125B | 157B | |||||
EBIT | 95.53B | 110B | 96.5B | 106B | 139B | |||||
EBITDAR | 143B | 164B | 153B | 164B | 195B | |||||
Effective Tax Rate - (Ratio) | 12.78 | 16.97 | 36.29 | 19.17 | 24 | |||||
Current Domestic Taxes | - | - | - | - | - | |||||
Total Current Taxes | 24B | 26.04B | 28.18B | 17.27B | 27.79B | |||||
Deferred Domestic Taxes | - | - | - | - | - | |||||
Total Deferred Taxes | -3.44B | 3.24B | -1.37B | -1.72B | -5.26B | |||||
Normalized Net Income | 112B | 128B | 87.95B | 68.44B | 89.42B | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 30.95B | 57.07B | 91.1B | 76.82B | 88.22B | |||||
Selling and Marketing Expenses | 50.67B | 81.52B | 120B | 103B | 115B | |||||
General and Administrative Expenses | 28.2B | 37B | 31.92B | 42.18B | 41.98B | |||||
Research And Development Expense From Footnotes | 43.08B | 57.24B | 55.46B | 56.74B | 52.26B | |||||
Net Rental Expense, Total | 5.68B | 6.86B | 10.98B | 10.8B | 11.41B | |||||
Imputed Operating Lease Interest Expense | 1.67B | 1.49B | 2.41B | 2.75B | 3.62B | |||||
Imputed Operating Lease Depreciation | 4.01B | 5.36B | 8.57B | 8.05B | 7.79B | |||||
Stock-Based Comp., COGS (Total) | 7.32B | 11.22B | 5.72B | 5.71B | 3.01B | |||||
Stock-Based Comp., R&D Exp. (Total) | 13.65B | 21.47B | 11.04B | 13.51B | 7.62B | |||||
Stock-Based Comp., S&M Exp. (Total) | 3.83B | 5.32B | 3.05B | 3.71B | 2.26B | |||||
Stock-Based Comp., G&A Exp. (Total) | 6.94B | 12.1B | 4.16B | 7.9B | 5.65B | |||||
Total Stock-Based Compensation | 31.74B | 50.12B | 23.97B | 30.83B | 18.55B |